BeOne Medicines
ONC
#670
Rank
A$55.46 B
Marketcap
A$490.33
Share price
-2.40%
Change (1 day)
-0.68%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Financial Statements

Thumbnail BeOne Medicines Financial Statement 2025

Financial Statement 2025

Language: English

View Financial Statement